» Articles » PMID: 29200583

Lurasidone-induced Oculogyric Crisis

Overview
Publisher Sage Publications
Specialty Psychiatry
Date 2017 Dec 5
PMID 29200583
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Characteristics of eye disorders induced by atypical antipsychotics: a real-world study from 2016 to 2022 based on Food and Drug Administration Adverse Event Reporting System.

Mu C, Chen L Front Psychiatry. 2024; 15:1322939.

PMID: 39156610 PMC: 11327930. DOI: 10.3389/fpsyt.2024.1322939.


Oculogyric crisis symptoms related to risperidone treatment: a case report.

Lv T, Wu L, Li L, Zhang M, Tan Q, Liu P BMC Psychiatry. 2023; 23(1):875.

PMID: 38001400 PMC: 10675969. DOI: 10.1186/s12888-023-05379-3.


Spotlight on Oculogyric Crisis: A Review.

Mahal P, Suthar N, Nebhinani N Indian J Psychol Med. 2021; 43(1):5-9.

PMID: 34349300 PMC: 8295578. DOI: 10.1177/0253717620942096.


Severe Extrapyramidal Syndrome Caused by Lurasidone Low Dose.

Das S, Andi B J Neurosci Rural Pract. 2018; 9(3):446-448.

PMID: 30069116 PMC: 6050779. DOI: 10.4103/jnrp.jnrp_571_17.

References
1.
Paul S, Cooke B, Nguyen M . Glossopharyngeal Dystonia Secondary to a Lurasidone-Fluoxetine CYP-3A4 Interaction. Case Rep Psychiatry. 2013; 2013:136194. PMC: 3670573. DOI: 10.1155/2013/136194. View

2.
Bawa R, Scarff J . Lurasidone: a new treatment option for bipolar depression-a review. Innov Clin Neurosci. 2015; 12(1-2):21-3. PMC: 4382136. View

3.
Barow E, Schneider S, Bhatia K, Ganos C . Oculogyric crises: Etiology, pathophysiology and therapeutic approaches. Parkinsonism Relat Disord. 2016; 36:3-9. DOI: 10.1016/j.parkreldis.2016.11.012. View